Abalonex, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury (NCT06096415) | Abalonex, LLC | 2023-12-01 |
Track Abalonex, LLC automatically
Every clearance here is in the API, with alerts when new ones post.